Connect AccountAll persons or entities that purchased or otherwise acquired any shares of the common stock of CTI BioPharma Corp. (“CTI”), CTI Series N-1 Preferred Stock, or CTI Series N-2 Preferred Stock, other than shares of such securities that traded on an exchange outside the United States (collectively, the “CTI Securities”), and were damaged thereby during the period from March 9, 2015 through February 9, 2016, inclusive.
Disbursed
March 09, 2015 - February 09, 2016
February 01, 2018
January 11, 2018
N/A
Garden City Group, LLC
In re CTI BioPharma Corp. Securities Litigation
c/o GCG
P.O. Box 35100
Seattle, WA 98124-1100
+1 844-402-8599
info@CTIBioPharmaSecuritiesSettlement.com
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.